A 2289

New York Assembly bill in Session 2025-2026.

Status: in_committee. Latest action: January 7, 2026.

Enacts the manufacturer disclosure and transparency act.

Bill ID NY-2025-2026-A-2289

Session 2025-2026

Status in_committee

Committee Consumer Affairs And Protection

Assembly in_committee 2026-01-07

Summary

Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.

Sponsor

Emily Gallagher

Official Source Back to Bills

Actions Timeline

Date	Event	Detail
2025-01-16	Introduced	Bill introduced
2026-01-07	Status	in_committee
2026-01-07	Latest Action	In Assembly Committee

More Bills From This Sponsor

A 4525

Prohibits the sale and distribution of anti-fogging sprays or wipes containing perfluoroalkyl and polyfluoroalkyl substances

in_committee • Assembly

A 10883

Authorizes the city of New York to sell certain lands now or formerly under the waters of Whale Creek otherwise known as Wyckoff Creek, which was a tributary of Newtown Creek

in_committee • Assembly

A 9111

Relates to portable solar generation devices

in_committee • Assembly

A 2300

Creates the substance use disorder treatment bill of rights to be posted in a conspicuous place in all treatment facilities

in_committee • Assembly

A 10210

Establishes the crime of corporate catastrophe

in_committee • Assembly

A 10071

Requires gas corporations to file maps with the public service commission

in_committee • Assembly